270 related articles for article (PubMed ID: 9751723)
1. Prion protein NMR structure and familial human spongiform encephalopathies.
Riek R; Wider G; Billeter M; Hornemann S; Glockshuber R; Wüthrich K
Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11667-72. PubMed ID: 9751723
[TBL] [Abstract][Full Text] [Related]
2. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
Liemann S; Glockshuber R
Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
[TBL] [Abstract][Full Text] [Related]
3. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism at residue 129 modulates the conformational conversion of the D178N variant of human prion protein 90-231.
Apetri AC; Vanik DL; Surewicz WK
Biochemistry; 2005 Dec; 44(48):15880-8. PubMed ID: 16313190
[TBL] [Abstract][Full Text] [Related]
5. NMR structure of the mouse prion protein domain PrP(121-231).
Riek R; Hornemann S; Wider G; Billeter M; Glockshuber R; Wüthrich K
Nature; 1996 Jul; 382(6587):180-2. PubMed ID: 8700211
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
7. The prion protein globular domain and disease-related mutants studied by molecular dynamics simulations.
Billeter M; Wüthrich K
Arch Virol Suppl; 2000; (16):251-63. PubMed ID: 11214929
[TBL] [Abstract][Full Text] [Related]
8. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
[TBL] [Abstract][Full Text] [Related]
9. Formation of soluble oligomers and amyloid fibrils with physical properties of the scrapie isoform of the prion protein from the C-terminal domain of recombinant murine prion protein mPrP-(121-231).
Martins SM; Frosoni DJ; Martinez AM; De Felice FG; Ferreira ST
J Biol Chem; 2006 Sep; 281(36):26121-8. PubMed ID: 16844683
[TBL] [Abstract][Full Text] [Related]
10. The role of PrP in health and disease.
Flechsig E; Weissmann C
Curr Mol Med; 2004 Jun; 4(4):337-53. PubMed ID: 15354865
[TBL] [Abstract][Full Text] [Related]
11. Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible.
Donne DG; Viles JH; Groth D; Mehlhorn I; James TL; Cohen FE; Prusiner SB; Wright PE; Dyson HJ
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13452-7. PubMed ID: 9391046
[TBL] [Abstract][Full Text] [Related]
12. Spongiform encephalopathy in transgenic mice expressing a point mutation in the β2-α2 loop of the prion protein.
Sigurdson CJ; Joshi-Barr S; Bett C; Winson O; Manco G; Schwarz P; Rülicke T; Nilsson KP; Margalith I; Raeber A; Peretz D; Hornemann S; Wüthrich K; Aguzzi A
J Neurosci; 2011 Sep; 31(39):13840-7. PubMed ID: 21957246
[TBL] [Abstract][Full Text] [Related]
13. Prion protein NMR structure from tammar wallaby (Macropus eugenii) shows that the beta2-alpha2 loop is modulated by long-range sequence effects.
Christen B; Hornemann S; Damberger FF; Wüthrich K
J Mol Biol; 2009 Jun; 389(5):833-45. PubMed ID: 19393664
[TBL] [Abstract][Full Text] [Related]
14. A proposed mechanism for the promotion of prion conversion involving a strictly conserved tyrosine residue in the β2-α2 loop of PrPC.
Kurt TD; Jiang L; Bett C; Eisenberg D; Sigurdson CJ
J Biol Chem; 2014 Apr; 289(15):10660-10667. PubMed ID: 24596090
[TBL] [Abstract][Full Text] [Related]
15. Conformational diversity in prion protein variants influences intermolecular beta-sheet formation.
Lee S; Antony L; Hartmann R; Knaus KJ; Surewicz K; Surewicz WK; Yee VC
EMBO J; 2010 Jan; 29(1):251-62. PubMed ID: 19927125
[TBL] [Abstract][Full Text] [Related]
16. Prion protein interconversions and the transmissible spongiform encephalopathies.
Horiuchi M; Caughey B
Structure; 1999 Oct; 7(10):R231-40. PubMed ID: 10545332
[TBL] [Abstract][Full Text] [Related]
17. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure.
Cobb NJ; Sönnichsen FD; McHaourab H; Surewicz WK
Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18946-51. PubMed ID: 18025469
[TBL] [Abstract][Full Text] [Related]
18. Inverse correlation of thermal lability and conversion efficiency for five prion protein polymorphic variants.
Kirby L; Agarwal S; Graham JF; Goldmann W; Gill AC
Biochemistry; 2010 Feb; 49(7):1448-59. PubMed ID: 20085368
[TBL] [Abstract][Full Text] [Related]
19. Unraveling the details of prion (con)formation(s): recent advances by mass spectrometry.
Principe S; Maras B; Schininà ME; Pocchiari M; Cardone F
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):697-707. PubMed ID: 18729021
[TBL] [Abstract][Full Text] [Related]
20. Structuring the puzzle of prion propagation.
Eghiaian F
Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
